Presentation is loading. Please wait.

Presentation is loading. Please wait.

Insulin and glucagon secretion: nondiabetic and diabetic subjects.

Published byLinnéa Eliasson Modified over 6 years ago

Similar presentations

Presentation on theme: "Insulin and glucagon secretion: nondiabetic and diabetic subjects."— Presentation transcript:

1 Insulin and glucagon secretion: nondiabetic and diabetic subjects.
Insulin and glucagon secretion: nondiabetic and diabetic subjects. In nondiabetic subjects (left panel), glucose-stimulated insulin and amylin release from the β-cells results in suppression of postprandial glucagon secretion. In a subject with type 1 diabetes, infused insulin does not suppress α-cell production of glucagon. Adapted from Ref. 38. Stephen L. Aronoff et al. Diabetes Spectr 2004;17: ©2004 by American Diabetes Association

Download ppt "Insulin and glucagon secretion: nondiabetic and diabetic subjects."

Similar presentations

Role of Amylin and Glucagon in Postprandial Glycemic Excursions in Pediatric Type 1 Diabetes. Rubina Heptulla MD, Luisa M. Rodriguez MD and Morey W. Haymond.

Role of Amylin and Glucagon in Postprandial Glycemic Excursions in Pediatric Type 1 Diabetes. Rubina Heptulla MD, Luisa M. Rodriguez MD and Morey W. Haymond.
Philip J. Barter, et al. Circulation 2011;124:555-562.

Philip J. Barter, et al. Circulation 2011;124:
GLP-1 Effectiveness, Mechanisms of Action and Potential Part 2.

GLP-1 Effectiveness, Mechanisms of Action and Potential Part 2.
Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.

Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.
Sofie Hædersdal, MD, Asger Lund, MD, PhD, Filip K

Sofie Hædersdal, MD, Asger Lund, MD, PhD, Filip K
Glucose homeostasis: roles of insulin and glucagon. 1A.

Glucose homeostasis: roles of insulin and glucagon. 1A.
Safia Costes, Peter C. Butler  Cell Metabolism 

Safia Costes, Peter C. Butler  Cell Metabolism 
Pramlintide Synthetic analog of the β-cell hormone amylin

Pramlintide Synthetic analog of the β-cell hormone amylin
Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.

Glucose homeostasis: roles of insulin, glucagon, amylin, and GLP-1.
1.

1.
Postprandial glucose flux in nondiabetic controls.

Postprandial glucose flux in nondiabetic controls.
Update on cystic fibrosis-related diabetes

Update on cystic fibrosis-related diabetes
Topic 6.5.8 – 6.5.12 Homeostasis Stephen Taylor.

Topic – Homeostasis Stephen Taylor.
Comparison of triglycerides AUC 480’ between IGT+reduced FPIS group, IGT+preserved FPIS group, and IGT+reduced FPIS+reduced FPIS and FPIS restitution with.

Comparison of triglycerides AUC 480’ between IGT+reduced FPIS group, IGT+preserved FPIS group, and IGT+reduced FPIS+reduced FPIS and FPIS restitution with.
Central nervous system BDNF infusion fails to increase tissue glucose uptake in uncontrolled insulin-deficient diabetes. Central nervous system BDNF infusion.

Central nervous system BDNF infusion fails to increase tissue glucose uptake in uncontrolled insulin-deficient diabetes. Central nervous system BDNF infusion.
Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.

Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.
Hyperinsulinemic-euglycemic clamp–derived insulin sensitivity (glucose disposal), model-derived insulin secretion parameters (sensitivity first-phase insulin.

Hyperinsulinemic-euglycemic clamp–derived insulin sensitivity (glucose disposal), model-derived insulin secretion parameters (sensitivity first-phase insulin.
The development of plasma (p-)C-peptide responses to an intravenous glucose (0.5 g glucose/kg body wt) and glucagon (1 mg) infusion test up to 5–7 years.

The development of plasma (p-)C-peptide responses to an intravenous glucose (0.5 g glucose/kg body wt) and glucagon (1 mg) infusion test up to 5–7 years.
Correlation between muscle Hsp-72 mRNA expression and rates of glucose and lipid turnover, as determined in protocol 2 (n = 36). Correlation between muscle.

Correlation between muscle Hsp-72 mRNA expression and rates of glucose and lipid turnover, as determined in protocol 2 (n = 36). Correlation between muscle.
Involvement of IRS-1 in L-783,281–stimulated increases in [Ca2+]i and exocytosis. Involvement of IRS-1 in L-783,281–stimulated increases in [Ca2+]i and.

Involvement of IRS-1 in L-783,281–stimulated increases in [Ca2+]i and exocytosis. Involvement of IRS-1 in L-783,281–stimulated increases in [Ca2+]i and.

Similar presentations

Ads by Google